- Home
- LTBR vs PRTA Comparison
LTBR vs PRTA Comparison
Compare LTBR & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTBR
- PRTA
- Stock Information
- Founded
- LTBR 1992
- PRTA 2012
- Country
- LTBR United States
- PRTA Ireland
- Employees
- LTBR N/A
- PRTA N/A
- Industry
- LTBR Professional Services
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- LTBR Consumer Discretionary
- PRTA Health Care
- Exchange
- LTBR Nasdaq
- PRTA Nasdaq
- Market Cap
- LTBR 397.8M
- PRTA 472.1M
- IPO Year
- LTBR N/A
- PRTA N/A
- Fundamental
- Price
- LTBR $22.89
- PRTA $10.29
- Analyst Decision
- LTBR
- PRTA Buy
- Analyst Count
- LTBR 0
- PRTA 9
- Target Price
- LTBR N/A
- PRTA $13.14
- AVG Volume (30 Days)
- LTBR 2.7M
- PRTA 733.6K
- Earning Date
- LTBR 10-30-2025
- PRTA 11-11-2025
- Dividend Yield
- LTBR N/A
- PRTA N/A
- EPS Growth
- LTBR N/A
- PRTA N/A
- EPS
- LTBR N/A
- PRTA N/A
- Revenue
- LTBR N/A
- PRTA $10,341,000.00
- Revenue This Year
- LTBR N/A
- PRTA N/A
- Revenue Next Year
- LTBR N/A
- PRTA $602.32
- P/E Ratio
- LTBR N/A
- PRTA N/A
- Revenue Growth
- LTBR N/A
- PRTA N/A
- 52 Week Low
- LTBR $2.91
- PRTA $4.32
- 52 Week High
- LTBR $24.78
- PRTA $18.88
- Technical
- Relative Strength Index (RSI)
- LTBR 66.97
- PRTA 78.54
- Support Level
- LTBR $21.40
- PRTA $9.58
- Resistance Level
- LTBR $24.78
- PRTA $10.37
- Average True Range (ATR)
- LTBR 2.23
- PRTA 0.44
- MACD
- LTBR 0.27
- PRTA 0.08
- Stochastic Oscillator
- LTBR 79.53
- PRTA 92.21
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.